Clinical Trial: Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07209475) titled 'Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.' on Oct. 02.

Brief Summary: This study will evaluate a cellular, acellular, matrix-like product (CAMP) and Standard of Care (SOC) versus SOC alone in the closure of nonhealing diabetic foot ulcers (DFUs). The study will evaluate Amnio-Maxx(R) Dual Layer Amnion Patch.

Study Start Date: Aug. 14

Study Type: INTERVENTIONAL

Condition: Diabetic Foot Ulcer (DFU) Amnio-Maxx

Intervention: BIOLOGICAL: Amnio-Maxx(R) Dual Layer Amnion Patch

Application of Amnio-Maxx(R) Dual Layer Amnion Patch

OTHER: Standard of Care (Investigator Choice)

Cleansing, debridement, wo...